Clinical trial
The Use of Incretin-based Drugs and the Risk of Pancreatic Cancer in Patients With Type 2 Diabetes
NCT02475499 is registered in ClinicalTrials.gov with Canadian Network for Observational Drug Effect Studies, CNODES as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Incretin-based Drugs and the Risk of Pancreatic Cancer in Patients With Type 2 Diabetes
- Lead sponsor
- Canadian Network for Observational Drug Effect Studies, CNODES
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- April 30, 2015
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.